MX2011010783A - Una crema medicinal hecha con crema de sulfato de framicetina y quitosano y un proceso para hacerla. - Google Patents
Una crema medicinal hecha con crema de sulfato de framicetina y quitosano y un proceso para hacerla.Info
- Publication number
- MX2011010783A MX2011010783A MX2011010783A MX2011010783A MX2011010783A MX 2011010783 A MX2011010783 A MX 2011010783A MX 2011010783 A MX2011010783 A MX 2011010783A MX 2011010783 A MX2011010783 A MX 2011010783A MX 2011010783 A MX2011010783 A MX 2011010783A
- Authority
- MX
- Mexico
- Prior art keywords
- cream
- skin
- composition
- chitosan
- skin infections
- Prior art date
Links
- 239000006071 cream Substances 0.000 title abstract 4
- 229920001661 Chitosan Polymers 0.000 title abstract 3
- OIXVKQDWLFHVGR-WQDIDPJDSA-N neomycin B sulfate Chemical compound OS(O)(=O)=O.N[C@@H]1[C@@H](O)[C@H](O)[C@H](CN)O[C@@H]1O[C@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](N)C[C@@H](N)[C@@H]2O)O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CN)O2)N)O[C@@H]1CO OIXVKQDWLFHVGR-WQDIDPJDSA-N 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 abstract 4
- 230000001580 bacterial effect Effects 0.000 abstract 3
- 206010040872 skin infection Diseases 0.000 abstract 3
- 239000004480 active ingredient Substances 0.000 abstract 2
- 239000008186 active pharmaceutical agent Substances 0.000 abstract 2
- 229920001222 biopolymer Polymers 0.000 abstract 2
- 230000003716 rejuvenation Effects 0.000 abstract 2
- 206010017543 Fungal skin infection Diseases 0.000 abstract 1
- 206010020751 Hypersensitivity Diseases 0.000 abstract 1
- 208000003251 Pruritus Diseases 0.000 abstract 1
- 206010052428 Wound Diseases 0.000 abstract 1
- 208000027418 Wounds and injury Diseases 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 150000007513 acids Chemical class 0.000 abstract 1
- 208000026935 allergic disease Diseases 0.000 abstract 1
- 230000007815 allergy Effects 0.000 abstract 1
- 239000003242 anti bacterial agent Substances 0.000 abstract 1
- 230000000844 anti-bacterial effect Effects 0.000 abstract 1
- 239000003963 antioxidant agent Substances 0.000 abstract 1
- 230000003078 antioxidant effect Effects 0.000 abstract 1
- 235000006708 antioxidants Nutrition 0.000 abstract 1
- 239000006172 buffering agent Substances 0.000 abstract 1
- 239000002738 chelating agent Substances 0.000 abstract 1
- 239000003995 emulsifying agent Substances 0.000 abstract 1
- 239000003906 humectant Substances 0.000 abstract 1
- 230000007803 itching Effects 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 239000008250 pharmaceutical cream Substances 0.000 abstract 1
- 239000003755 preservative agent Substances 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
Abstract
La presente invención se refiere a una composición para el tratamiento de infecciones bacterianas en la piel junto con el rejuvenecimiento e la piel. Más particularmente, la presente invención se refiere a una crema farmacéutica que comprende un biopolímero, y un ingrediente activo antibacteriano. Divulga una composición para el tratamiento de infecciones fúngicas en la piel junto con el rejuvenecimiento de la piel que contiene a) un biopolímero en la forma de a) quitosano, b) un ingrediente farmacéutico activo (IFAs) en la forma de sulfato de framicetina utilizado en el tratamiento de infecciones bacteriana en la piel, c) una crema base que contiene emulsificantes primarios y secundarios, materiales de cera, co-solventes, ácidos, conservadores, agentes amortiguadores, antioxidantes, agentes quelante, y humectantes, y d) agua. Los ingredientes activos, a saber quitosano, y un agente antibacteriano en la forma de Sulfato de Framicetina, son incorporados en una crema base para utilizar en el tratamiento de infecciones bacterianas en la piel, picazón y heridas en la piel humana que involucra el contacto de la piel humana con la composición identificada anteiormente.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN956MU2009 | 2009-04-13 | ||
| PCT/IB2010/051550 WO2010119383A1 (en) | 2009-04-13 | 2010-04-12 | A medicinal cream made using framycetin sulphate cream and chitosan, and a process to make it |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2011010783A true MX2011010783A (es) | 2011-12-14 |
Family
ID=42272352
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2011010783A MX2011010783A (es) | 2009-04-13 | 2010-04-12 | Una crema medicinal hecha con crema de sulfato de framicetina y quitosano y un proceso para hacerla. |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20120101056A1 (es) |
| JP (1) | JP2012523450A (es) |
| CN (1) | CN102427801A (es) |
| IL (1) | IL215640A0 (es) |
| MX (1) | MX2011010783A (es) |
| RU (1) | RU2536266C2 (es) |
| WO (1) | WO2010119383A1 (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105492004A (zh) * | 2013-02-08 | 2016-04-13 | 罗达制药有限公司 | 治疗局部微生物感染的方法 |
| US9248160B1 (en) * | 2015-07-28 | 2016-02-02 | Zo Skin Health, Inc. | Post-procedure skin care systems, compositions, and methods of use thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4946870A (en) * | 1986-06-06 | 1990-08-07 | Union Carbide Chemicals And Plastics Company Inc. | Delivery systems for pharmaceutical or therapeutic actives |
| US5516808A (en) * | 1994-10-27 | 1996-05-14 | Sawaya; Assad S. | Topical cellulose pharmaceutical formulation |
| US20080206161A1 (en) * | 2002-10-25 | 2008-08-28 | Dov Tamarkin | Quiescent foamable compositions, steroids, kits and uses thereof |
-
2010
- 2010-04-12 JP JP2012505267A patent/JP2012523450A/ja not_active Withdrawn
- 2010-04-12 CN CN2010800219201A patent/CN102427801A/zh active Pending
- 2010-04-12 US US13/263,847 patent/US20120101056A1/en not_active Abandoned
- 2010-04-12 MX MX2011010783A patent/MX2011010783A/es not_active Application Discontinuation
- 2010-04-12 RU RU2011146231/15A patent/RU2536266C2/ru not_active Application Discontinuation
- 2010-04-12 WO PCT/IB2010/051550 patent/WO2010119383A1/en not_active Ceased
-
2011
- 2011-10-09 IL IL215640A patent/IL215640A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2012523450A (ja) | 2012-10-04 |
| RU2011146231A (ru) | 2013-05-20 |
| US20120101056A1 (en) | 2012-04-26 |
| RU2536266C2 (ru) | 2014-12-20 |
| IL215640A0 (en) | 2012-01-31 |
| WO2010119383A1 (en) | 2010-10-21 |
| CN102427801A (zh) | 2012-04-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2011010781A (es) | Una crema medicinal hecha con sulfadiazina de plata y quitosano y un proceso para hacerla. | |
| WO2010119364A3 (en) | A medicinal cream made using neomycin sulphate, betamethasone valerate, and chitosan, and a process to make the same | |
| WO2010109434A3 (en) | A medicinal antibacterial, antifungal and steroids cream comprising chitosan and a process to make it | |
| BRPI1007379B8 (pt) | composições farmacêuticas para o tratamento ou prevenção de infecções orais por e. coli | |
| ZA202300259B (en) | Compound for the treatment of coronaviral infections | |
| WO2010109425A3 (en) | A medicinal steroids cream and a process to make it | |
| RU2012149863A (ru) | Полисахарид семени тамаринда для применения в лечении микробных инфекций | |
| MX2011012143A (es) | Composiciones adecuadas para el tratamiento topico o infecciones fungicas de la piel y uñas. | |
| WO2018094023A3 (en) | Cyclic dipeptides and wound healing | |
| PT2459153E (pt) | Composição farmacêutica ou cosmética ou dietética tendo o efeito de favorecer a pigmentação capilar | |
| EP4272832A3 (en) | Antimicrobial compounds, compositions, and uses thereof | |
| WO2010119366A3 (en) | A medicinal cream made using fluticasone propionate, and chitosan, and a process to make the same | |
| WO2021046315A3 (en) | Inhibitors of encephalitic alphaviruses | |
| NZ759173A (en) | Antibacterial activity of galactooligosaccharide and xylitol in dermatological treatments | |
| WO2010122490A3 (en) | A medicinal anti diaper rash cream incorporating a biopolymer and a process to make it | |
| MX2022013952A (es) | Pulverizador de acido tranexamico para la artroplastia de rodilla. | |
| WO2010119367A3 (en) | A medicinal cream made using hydrocortisone acetate and a process to make the same | |
| WO2013092457A3 (de) | Wirkstoffkombinationen aus einer oder mehreren carbonsäuren, insbesondere hydroxycarbonsäuren, und einer oder mehreren physiologisch unbedenklichen hydroxamsäure sowie kosmetische oder dermatologische zubereitungen, solche wirkstoffkombinationen enthaltend | |
| MX2011010783A (es) | Una crema medicinal hecha con crema de sulfato de framicetina y quitosano y un proceso para hacerla. | |
| SG11201909144VA (en) | Bacterial secretome for use in the treatment of skin lesions | |
| EA202092077A1 (ru) | Местные составы, содержащие стронций и метилсульфонилметан (мсм), и способы лечения | |
| HK1201189A1 (en) | Use of amphoteric surfactants for the prevention and treatment of pathogenic vaginal biofilms in vaginal infections | |
| WO2019004788A3 (ko) | 브라우쏘칼콘 a를 유효성분으로 포함하는 염증성 장질환 예방 또는 치료용 약학 조성물 | |
| EP4344749A3 (en) | Protease formulation for treatment of microbial infections | |
| WO2010119384A3 (en) | A medicinal cream made using mometasone furoate, and chitosan, and a process to make the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |